Metabolic and Endocrine Alterations in Underweight and Normal-Weight Women with Functional Hypothalamic Amenorrhea
Journal of Clinical Medicine · 07.10.2025 · 14 (19) · 7082
DOI: 10.3390/jcm14197082 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 07.10.2025. Verfasst von Karolina Kowalczyk und 5 weiteren Autor:innen. Beteiligte Einrichtung: Chair and Department of Gynecology, Obstetrics and Oncological Gynecology, Medical University of Silesia, 40-211 Katowice, Poland. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Functional hypothalamic amenorrhea (FHA) is a form of chronic anovulation associated with hypoestrogenism. Weight loss, excessive exercise, stress and long-lasting hypoestrogenism lead to infertility and bone loss. FHA also leads to metabolic changes that increase cardiovascular risk in women who otherwise appear metabolically healthy.
Methods
This was a case–control study assessing metabolic and endocrine alterations in patients with FHA, stratified by BMI into underweight (BMI < 18.5) and normal-weight (BMI 18.5–24.99) categories.
Results
Women diagnosed with FHA had significantly higher levels of total (193 ± 41.96 vs. 181 ± 28.23 mg/dL; p = 0.037) and LDL cholesterol (67 ± 34.89 vs. 63 ± 24.78 mg/dL; p = 0.018) compared with healthy controls. HDL cholesterol levels did not differ between groups; however, normal-weight participants in the study group had higher HDL cholesterol than underweight participants (p = 0.007). FHA patients had significantly lower HOMA-IR (p = 0.001), lower prolactin (p < 0.001), and higher cortisol levels (p = 0.036).
Conclusions
Metabolic and endocrine alterations in FHA patients are modulated both by the condition per se and by BMI. FHA influences total and LDL cholesterol, prolactin, and cortisol levels, while BMI primarily affects HDL cholesterol. Both FHA and BMI have a statistically significant impact on HOMA-IR, but neither influences triglycerides or TSH levels. Our findings indicate that the recovery and prevention of metabolic complications require psychological support and consistent weight management.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Chair and Department of Gynecology, Obstetrics and Oncological Gynecology, Medical University of Silesia, 40-211 Katowice, Poland.
- Student Scientific Society at the Department of Gynecological Endocrinology, Medical University of Silesia, 40-752 Katowice, Poland.
- Department of Gynecological Endocrinology, School of Medicine in Katowice, Medical University of Silesia, 40-752 Katowice, Poland.
ORCID-Profile: Karolina Kowalczyk, Agnieszka Drosdzol-Cop, Paweł Madej
Zitieren
APA
Kowalczyk, K., Szymańska, I., Zawistowska, O., Bieńkowska, J., Drosdzol-Cop, A., & Madej, P. (2025). Metabolic and Endocrine Alterations in Underweight and Normal-Weight Women with Functional Hypothalamic Amenorrhea. Journal of Clinical Medicine, 14(19), 7082. https://doi.org/10.3390/jcm14197082
Vancouver
Kowalczyk K, Szymańska I, Zawistowska O, Bieńkowska J, Drosdzol-Cop A, Madej P. Metabolic and Endocrine Alterations in Underweight and Normal-Weight Women with Functional Hypothalamic Amenorrhea. Journal of Clinical Medicine. 2025;14(19):7082. doi:10.3390/jcm14197082
BibTeX
@article{Kowalczyk2025,
author = {Kowalczyk, Karolina and Szymańska, Iga and Zawistowska, Olga and Bieńkowska, Julia and Drosdzol-Cop, Agnieszka and Madej, Paweł},
title = {Metabolic and Endocrine Alterations in Underweight and Normal-Weight Women with Functional Hypothalamic Amenorrhea},
journal = {Journal of Clinical Medicine},
year = {2025},
volume = {14},
number = {19},
pages = {7082},
doi = {10.3390/jcm14197082}
}
EUVIMED